Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In CVS Health Corporation To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in CVS Health Corporation ("CVS Health" or the "Company")(NYSE: CVS) of the April 26, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
If you invested in CVS Health stock or options between May 21, 2015 and February 20, 2019 and would like to discuss your legal rights, please fill out the form below. There is no cost or obligation to you.
You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to firstname.lastname@example.org.
The lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of all those who purchased CVS Health securities between May 21, 2015 and February 20, 2019 (the "Class Period"). The case, Anarkat v. CVS Health Corporation et al, No. 19-cv-01725 was filed on February 25, 2019.
The lawsuit focuses on whether the Company and its executives violated federal securities laws by failing to disclose that: (i) CVS Health’s financial condition and expected earnings were deteriorating as a result of rising costs and poor results associated with the Omnicare Acquisition; and (ii) as a result, CVS Health’s public statements were materially false and misleading at all relevant times.
On February 20, 2019, CVS Health announced the Company’s fourth quarter and full year financial and operating results and provided 2019 full year guidance. CVS Health advised investors that adjusted earnings in 2019 would be $6.68 to $6.88 per share, compared with the $7.36 average of market estimates, citing rising costs and poor results related to the Company’s 2015 acquisition of Omnicare.
On this news, CVS Health's share price fell from $69.88 per share on February 19, 2019 to a closing price of $64.22 on February 20, 2019: a $5.66 or a 8.0995% drop.
CVS Health Corporation (CVS)
* The submission of this form does not create an attorney-client relationship.
Filed on 02/26/2019
685 Third Avenue 26th Floor
10017 New York, New York
Phone (212) 983-9330
Fax (212) 983-9331
Richard W. Gonnello email@example.com Phone (212) 983-9330 Fax (212) 983-9331